Ketamine, at a dose that disrupts motor behavior and latent inhibition, enhances prefrontal cortex synaptic efficacy and glutamate release in the nucleus accumbens

Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
Florence RazouxIsabelle Léna

Abstract

Noncompetitive N-methyl-D-aspartate (NMDA) antagonists such as ketamine represent useful pharmacological tools to model, in both healthy humans and rodents, behavioral and cerebral abnormalities of schizophrenia. These compounds are thought to exert some of their disruptive effects by impairing glutamatergic transmission in corticolimbic circuits including the nucleus accumbens (NAc). In this study, we investigated in freely moving rats behavioral changes as well as electrophysiological and neurochemical alterations in the NAc following acute systemic injection of a subanesthetic dose (25 mg/kg) of ketamine. We found that ketamine induced an immediate behavioral activation, characterized by hyperlocomotion, stereotypies and ataxia, and abolished latent inhibition in a conditioned-fear paradigm when injected at the pre-exposure stage. We also observed that during expression of motor effects which are thought to be related to the positive symptoms of schizophrenia, ketamine potentiated synaptic efficacy in the prefrontal-accumbens pathway and increased the extracellular levels of glutamate in the NAc. These results, taken together with previous findings, suggest that the psychotic-like effects of noncompetitive NMDA antagonists m...Continue Reading

References

Oct 1, 1991·The American Journal of Psychiatry·D C Javitt, S R Zukin
Mar 1, 1990·Pharmacology, Biochemistry, and Behavior·E R Butelman
Aug 1, 1985·Archives of General Psychiatry·B BogertsR Schönfeldt-Bausch
Dec 1, 1995·Archives of General Psychiatry·J W Olney, N B Farber
Aug 1, 1995·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·A C LahtiC A Tamminga
May 1, 1996·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·A K MalhotraA Breier
Aug 20, 1996·Proceedings of the National Academy of Sciences of the United States of America·M LaruelleR B Innis
Mar 18, 1997·Proceedings of the National Academy of Sciences of the United States of America·A BreierD Pickar
Sep 1, 1997·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·A K MalhotraA Breier
Sep 16, 1998·Proceedings of the National Academy of Sciences of the United States of America·J G CsernanskyM I Miller
Mar 4, 1999·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·J D Jentsch, R H Roth
Dec 1, 1999·Biological Psychiatry·A CarlssonM L Carlsson
Jan 13, 2000·Archives of General Psychiatry·L A Glantz, D A Lewis
Mar 17, 2000·Brain Research. Brain Research Reviews·A A Grace
Jul 19, 2000·Pharmacology, Biochemistry, and Behavior·S M TurgeonW W Graves
Sep 30, 2000·Brain Research. Brain Research Reviews·P C MoserP M Moran
Mar 27, 2001·Neuroscience and Behavioral Physiology·L V Loskutova
Apr 18, 2003·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Peter OlaussonJane R Taylor
Apr 18, 2003·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Ryuichi Takahata, Bita Moghaddam
Aug 23, 2003·Neurobiology of Learning and Memory·L M TraversoL G De la Casa
Mar 1, 1959·A.M.A. Archives of Neurology and Psychiatry·E D LUBYR KELLEY
Nov 26, 2003·The American Journal of Psychiatry·Joseph H CallicottDaniel R Weinberger
Dec 20, 2003·Annals of the New York Academy of Sciences·Joseph T CoyleDonald Goff
Feb 6, 2004·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Anne Marie Brady, Patricio O'Donnell
May 26, 2004·Proceedings of the National Academy of Sciences of the United States of America·Mark E JacksonBita Moghaddam
Jan 14, 2005·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Mark J HuntRene Garcia

❮ Previous
Next ❯

Citations

May 22, 2013·Molecular Psychiatry·K MartinowichH K Manji
Nov 6, 2009·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·L Elliot HongAdrienne C Lahti
Jun 12, 2009·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Inna Gaisler-SalomonStephen Rayport
Jul 29, 2010·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Antonios Boultadakis, Nikolaos Pitsikas
Jul 12, 2008·International Anesthesiology Clinics·Christa J Van DortRalph Lydic
Aug 15, 2013·Cell and Tissue Research·Vincenzo MicaleAlexandra Sulcova
Aug 3, 2012·Expert Review of Neurotherapeutics·Andra MihaliInna Gaisler-Salomon
Dec 4, 2015·Medical Hypotheses·Ming-Chyi HuangShih-Ku Lin
Jun 3, 2008·Progress in Neuro-psychopharmacology & Biological Psychiatry·Mark J HuntStefan Kasicki
May 6, 2009·Basic & Clinical Pharmacology & Toxicology·Hui-Ru HsuHwei-Hsien Chen
Mar 28, 2013·Developmental Psychobiology·G Andrew MickleyNita Hoxha
Apr 12, 2016·Progress in Neuro-psychopharmacology & Biological Psychiatry·Anett SchumacherRutsuko Ito
Jun 28, 2012·Pharmacology, Biochemistry, and Behavior·Luis M TraversoLuis G De la Casa
May 17, 2015·Progress in Neuro-psychopharmacology & Biological Psychiatry·Andrea de BartolomeisFelice Iasevoli
Apr 23, 2015·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Jonathan FischellScott M Thompson
Apr 19, 2015·Trends in Neurosciences·Scott M ThompsonXiang Cai
Jan 28, 2017·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Josephine C McGowanChristine A Denny
Sep 20, 2018·PloS One·Katharina HohlbaumChrista Thöne-Reineke
Nov 11, 2009·Bulletin of Experimental Biology and Medicine·L V Loskutova, N V Kostjunina
Apr 20, 2011·Psychopharmacology·Jianjun YangChun Yang
Oct 17, 2008·Pharmacological Reviews·Jeffrey A LiebermanJohn G Csernansky
Jan 18, 2018·Journal of Psychopharmacology·Nicholas E CliftonJeremy Hall
Jan 14, 2020·Psychopharmacology·Summer L ThompsonStephanie C Dulawa
Nov 9, 2010·Human & Experimental Toxicology·L SunD T Yew

❮ Previous
Next ❯

Related Concepts

Related Feeds

Ataxias (MDS)

Ataxia is a neurological condition characterized by lack of voluntary coordination of muscle movements including loss of coordination, balance, and speech. Discover the latest research on ataxia here.

Ataxia

Ataxia is a neurological condition characterized by lack of voluntary coordination of muscle movements including loss of coordination, balance, and speech. Discover the latest research on ataxia here.

Ataxias

Ataxia is a neurological condition characterized by lack of voluntary coordination of muscle movements including loss of coordination, balance, and speech. Discover the latest research on different types of ataxias here.

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.